Cargando…
NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
Nonalcoholic fatty liver disease is a condition defined by fat accumulation in hepatocytes not promoted by excessive alcohol consumption. It is highly prevalent and is strongly associated with insulin resistance, metabolic syndrome, and diabetes type II. Insulin resistance plays a crucial role in th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904371/ https://www.ncbi.nlm.nih.gov/pubmed/33681089 http://dx.doi.org/10.1155/2021/6613827 |
_version_ | 1783654914580283392 |
---|---|
author | Marušić, Marinko Paić, Matej Knobloch, Mia Liberati Pršo, Ana-Marija |
author_facet | Marušić, Marinko Paić, Matej Knobloch, Mia Liberati Pršo, Ana-Marija |
author_sort | Marušić, Marinko |
collection | PubMed |
description | Nonalcoholic fatty liver disease is a condition defined by fat accumulation in hepatocytes not promoted by excessive alcohol consumption. It is highly prevalent and is strongly associated with insulin resistance, metabolic syndrome, and diabetes type II. Insulin resistance plays a crucial role in the multifactorial etiopathogenesis of this condition leading to accumulation of free fatty acids in the liver cells, thus causing lipotoxicity, inflammation, and fibrosis. In this review, we will focus on currently known pathogenesis of nonalcoholic fatty liver disease. Numerous investigation strategies are available to establish the diagnosis, from biochemical markers and ultrasound to various molecular and advanced imaging techniques and liver biopsy. Prevention is crucial. However, effective and promising therapies are strongly demanded. |
format | Online Article Text |
id | pubmed-7904371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-79043712021-03-04 NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2 Marušić, Marinko Paić, Matej Knobloch, Mia Liberati Pršo, Ana-Marija Can J Gastroenterol Hepatol Review Article Nonalcoholic fatty liver disease is a condition defined by fat accumulation in hepatocytes not promoted by excessive alcohol consumption. It is highly prevalent and is strongly associated with insulin resistance, metabolic syndrome, and diabetes type II. Insulin resistance plays a crucial role in the multifactorial etiopathogenesis of this condition leading to accumulation of free fatty acids in the liver cells, thus causing lipotoxicity, inflammation, and fibrosis. In this review, we will focus on currently known pathogenesis of nonalcoholic fatty liver disease. Numerous investigation strategies are available to establish the diagnosis, from biochemical markers and ultrasound to various molecular and advanced imaging techniques and liver biopsy. Prevention is crucial. However, effective and promising therapies are strongly demanded. Hindawi 2021-02-17 /pmc/articles/PMC7904371/ /pubmed/33681089 http://dx.doi.org/10.1155/2021/6613827 Text en Copyright © 2021 Marinko Marušić et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Marušić, Marinko Paić, Matej Knobloch, Mia Liberati Pršo, Ana-Marija NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2 |
title | NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2 |
title_full | NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2 |
title_fullStr | NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2 |
title_full_unstemmed | NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2 |
title_short | NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2 |
title_sort | nafld, insulin resistance, and diabetes mellitus type 2 |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904371/ https://www.ncbi.nlm.nih.gov/pubmed/33681089 http://dx.doi.org/10.1155/2021/6613827 |
work_keys_str_mv | AT marusicmarinko nafldinsulinresistanceanddiabetesmellitustype2 AT paicmatej nafldinsulinresistanceanddiabetesmellitustype2 AT knoblochmia nafldinsulinresistanceanddiabetesmellitustype2 AT liberatiprsoanamarija nafldinsulinresistanceanddiabetesmellitustype2 |